NewLeaf Symbiotics rakes in $30 mln Series C
St. Louis, Missouri-based NewLeaf Symbiotics, an agricultural biotech company, has raised $30 million in Series C funding. The investors included S2G Ventures, Monsanto Growth Ventures, Otter Capital, The Yard Ventures, Lewis & Clark Ventures, Rockport Capital, Pangaea Ventures and Open Prairie Ventures.
7 September 2017•1 min read
